Varicella-zoster-virus folliculitis promoted clonal cutaneous lymphoid hyperplasia

American Journal of Dermatopathology

Volumn 27, Issue 5, 2005, Pages 411-417

  Aram, Gazelle ^a   Rohwedder, Angela ^b   Nazeer, Tipu ^a   Shoss, Robert ^c   Fisher, Ari ^c   Carlson, J Andrew ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b Bio Med Mol Service   (Germany)

^c 2 Executive Park ^*  (United States)

Author keywords

Cutaneous lymphoid hyperplasia; Folliculitis; Herpetic dermatitis; Inflammation promoted neoplasia; Lymphoma; Varicella zoster virus; Vasculitis

Indexed keywords

VALACICLOVIR; VIRUS DNA;

AGED; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL PROLIFERATION; CUTANEOUS LYMPHOID HYPERPLASIA; FEMALE; FOLLICULITIS; GENE REARRANGEMENT; HERPES ZOSTER; HUMAN; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; INFLAMMATION; LYMPHOID HYPERPLASIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN NODULE; T LYMPHOCYTE; VARICELLA ZOSTER VIRUS;

ACYCLOVIR; AGED, 80 AND OVER; ANTIVIRAL AGENTS; ARTERITIS; CLONE CELLS; DNA, VIRAL; FEMALE; FOLLICULITIS; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOPHENOTYPING; POLYMERASE CHAIN REACTION; PSEUDOLYMPHOMA; VALINE;

EID: 25644455123     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.dad.0000178005.34515.7f     Document Type: Article

References (53)

1. Requena L, Kutzner H, Escalonilla P, et al. Cutaneous reactions at sites of herpes zoster scars: an expanded spectrum. Br J Dermatol. 1998;138: 161-168.
2. Talpur R, Duvic M. Atypical lymphoid infiltration occurring at the site of a healed varicella zoster infection. Clin Lymphoma. 2003;3:253-256.
3. Langenberg A, Yen TS, LeBoit PE. Granulomatous vasculitis occurring after cutaneous herpes zoster despite absence of viral genome. J Am Acad Dermatol. 1991;24:429-433.
4. Nikkels AF, Debrus S, Delvenne P, et al. Viral glycoproteins in herpcsviridac granulomas. Am J Dermatopathol. 1994;16:588-592.
5. Gibney MD, Nahass GT, Leonardi CL. Cutaneous reactions following herpes zoster infections: report of three cases and a review of the literature. Br J Dermatol. 1996;134:504-509.
6. Snow JL, el-Azhary RA, Gibson LE, et al. Granulomatous vasculitis associated with herpes virus: a persistent, painful, postherpetic papular eruption. Mayo Clin Proc. 1997;72:851-853.
7. Gutzmcr R, Kiehl P. Hausmann M, et al. [Post-zoster granuloma with detection of varicella zoster virus DNA in the granulomas.] Hautarzt. 2001;52:1111-1114.
8. Serfling U, Penneys NS, Zhu WY, et al. Varicella-zoster virus DNA in granulomatous skin lesions following herpes zoster. A study by the polymerase chain reaction. J Cutan Pathol. 1993;20:28-33.
9. Nikkels AF, Pierard GE. Are granulomatous reactions in old zoster lesions due to an immune response to varicella zoster virus envelope glucoprotcins? Clin Exp Dermatol. 1998;23:237-238.
10. Gilden DH, Kleinschmidt-DeMasters BK, Wellish M, et al. Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology. 1996;47:1441-1446.
11. Nikkels AF, Pierard GE. Necrotizing varicella zoster virus folliculitis. Enr J Dermatol. 2003;13:587-589.
12. Wolf R, Brenner S, Ruocco V, et al. Isotopic response. Int J Dermatol. 1995;34:341-348.
13. McCrary ML, Severson J, Tyring SK. Varicella zoster virus. J Am Acad Dermatol. 1999;41:1-14; quiz 15-6.
14. Abcndroth A, Arvin A. Varicella-zoster virus immune evasion. Immunol Rev. 1999;168:143-156.
15. Inghirami G, Szaboles MJ, Yee HT, et al. Detection of immunoglobulin gene rearrangement of B cell non-Hoclgkin's lymphomas and leukemias in fresh, unfixed and formal in-fixed, paraffin-embedded tissue by polymerase chain reaction. Lab Invest. 1993;68:746-757.
16. Slack DN, McCarthy KR, Wiedemann LM, et al. Evaluation of sensitivity, specificity, and reproducibility of an optimized method for detecting clonal rearrangements of immunoglobulin and T-cell receptor genes in formalin-fixed, paraffin-embedded sections. Diagn Mol Pathol. 1993;2: 223-232.
17. Arvin AM. Immune responses to varicella-zoster virus. Infect Dis Clin North Am. 1996;10:529-570.
18. Burke BL, Steele RW, Beard OW. et al. Immune responses to varicella-zoster in the aged. Arch Intern Med. 1982;142:291-293.
19. Levin MJ, Smith JG, Kaufhold RM, et al. Decline in varicella-zoster virus (VZV)-spceific cell-mediated immunity with increasing age and boosting with a high-hose VZV vaccine. J Infect Dis. 2003;188:1336-1344.
20. Smith JB, Fenske NA. Herpes zoster and internal malignancy. South Med J. 1995;88:1089-1092.
21. Ragozzino MW, Melton LJ 3rd, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore)2E 1982;61:310-316.
22. Zinkernagel RM. Immunology taught by viruses. Science. 1996;271:173-178.
23. Zinkernagel RM, Hengartner H. On immunity against infections and vaccines: credo 2004. Scand J Immunol. 2004;60:9-13.
24. Walsh N, Boutilier R, Glasgow D, et al. Exclusive Involvement of Folliculoscbaceous Units by Herpes: A Reflection of Early Herpes Zoster. Am J Dermatopathol. 2005;27:189-194.
25. Iwasaki T, Muraki R, Kasahara T, et al. Pathway of viral spread in herpes zoster: detection of the protein encoded by open reading frame 63 of varicella-zoster virus in biopsy specimens. Arch Virol Suppl. 2001;17: 109-119.
26. Nikkels AF, Pierard GE. Hair follicle involvement in herpes zoster. Virchows Arch. 1997;430:510-511.
27. Fernandez-Redondo V, Amrouni B, Varela E, et al. Granulomatous folliculitis at sites of herpes zoster scars: Wolf's isotopic response. J Eur Acad Dermatol Venereol. 2002;16:628-630.
28. Baalbaki SA, Malak JA, al-Khars MA, et al. Granulomatous vasculitis in herpes zoster scars. Int J Dermatol. 1994;33:268-269.
29. Mitchell BM, Font RL. Detection of varicella zoster virus DNA in some patients with giant cell arteritis. Invest Ophthalmol Vis Sci. 2001;42:2572-2577.
30. Erhard H, Runger TM, Kreienkamp M, et al. Atypical varicella-zoster virus infection in an immunocompromised patient: result of a virus-induced vasculitis. J Am Acad Dermatol. 1995;32:908-911.
31. Uhoda I, Pierard-Franchimont C, Pierard GE. Varicella-zoster virus vasculitis: a case of recurrent varicella without epidermal involvement. Dermatology. 2000;200:173-175.
32. Kalyoncu M, Odemis E, Yaris N, et al. Association of Henoch-Schonlein purpura with varicella zoster. Indian Pediatr. 2003;40:274-275.
33. Rodriguez-Pereira C, Suarez-Penaranda JM, del Rio E, et al. Cutaneous granulomatous vasculitis after herpes zoster infection showing poly-arteritis nodosa-like features. Clin Exp Dermatol. 1997;22:274-276.
34. Winkelmann RK, Connolly SM, Yiannias JA, et al. Postzoster eruptions: granuloma annulare, granulomaotus vasculitis and pseudolymphoma. Eur J Dermatol. 1995;5:470-476.
35. Shimizu J, Inatsu A, Oshima S, et al. Unique angiopathy after herpes virus infection. J Rheumatol. 2004;31:925-930.
36. Suwabe H, Yabe H, Tsutsumi Y. Relapsing hemorrhagic varicella. Pathol Int. 1996;46:605-609.
37. Martin JR, Mitchell WJ, Henken DB. Neurotropic herpesviruses, neural mechanisms and arteritis. Brain Pathol. 1990;1:6-10.
38. Carlson JA, Mihm MC Jr, LeBoit PE. Cutaneous lymphocytic vasculitis: a definition, a review, and a proposed classification. Semin Diagn Pathol. 1996;13:72-90.
39. Zinkernagel RM. Immunology and immunity studied with viruses. Ciba Found Symp. 1997;204:105-125; discussion 125-129.
40. Wagner M, Rose VA, Linder R, et al. Human pathogenic virus-associated pseudolymphomas and lymphomas with primary cutaneous manifestation in humans and animals. Clin Infect Dis. 1998;27:1299-1308.
41. Roo E, Villegas C, Lopez-Bran E, et al. Postzoster cutaneous pseudolymphoma. Arch Dermatol. 1994;130:661-663.
42. Wolff HH, Wendt V, Winzer M. Cutaneous pseudolymphoma at the site of prior herpes zoster eruption. Arch Dermatol Res. 1987;279(Suppl):S52-S54.
43. Sanchez JL, Mendez JA, Palacio R. Cutaneous pseudolymphoma at the site of resolving herpes zoster. Arch Dermatol. 1981;117:377.
44. Aloi FG, Appino A, Puiatti P. Lymphoplasmocytoid lymphoma arising in herpes zoster scars. J Am Acad Dermatol. 1990;22:130-131.
45. Paydas S, Sahin B, Yavuz S, et al. Lymphomatous skin infiltration at the site of previous varicella zoster virus infection in a patient with T cell lymphoma. Leuk Lymphoma. 2000;37:229-232.
46. Aberer W, Zonzits E, Soyer HP, et al. [Post-zoster-specific skin infiltrates in chronic lymphatic leukemia.] Hautarzt. 1990;41:455-457.
47. Bahadoran P, Lacour JP, Del Giudice P, et al. [Cutaneous localizations of chronic lymphoid leukemia in a zona area.] Ann Dermatol Venereol. 1996; 123:471-473.
48. Scheman AJ, Steinberg I, Taddeini L. Abatement of Sezary syndrome lesions following treatment with acyclovir. Am J Med. 1986;80:1199-1202.
49. Thun MJ, Henley SJ, Gansler T. Inflammation and cancer: an epidemiological perspective. Novartis Found Symp. 2004;256:6-21; discussion 22-28, 49-52, 266-269.
50. Burg G, Dummer R, Haeffner A, et al. From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol. 2001;137:949-952.
51. Nihal M, Mikkola D, Horvath N, et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum Pathol. 2003;34:617-622.
52. Isaacson PG. Update on MALT lymphomas. Best Pract Res Clin Haematol. 2005;18:57-68.
53. Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol. 1998;38:877-895; quiz 896-897.